COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,284 Articles (22,759 medRxiv, 8,525 bioRxiv)

Most recent first Previous |  Page 1893: Articles 18921-18930  | Next

Development and evaluation of rapid data-enabled access to routine clinical information to enhance early recruitment to the national clinical platform trial of COVID-19 community treatments
Cake, C., Ogburn, E., Pinches, H., Coleman, G., Seymour, D., Woodard, F., Manohar, S., Monsur, M., Landray, M., Dalton, G., Morris, A. D., Chinnery, P. F., UK COVID-19 National Core Studies Consortium, , Hobbs, F. D. R., Butler, C.
10.1101/2021.01.15.21249724 — Posted: 2021-01-15
From "don, doff, and discard" to "don, doff, and decontaminate" - determination of filtering facepiece respirator and surgical mask integrity and inactivation of a SARS-CoV-2 surrogate and a small non-enveloped virus following multiple-cycles of vaporised hydrogen peroxide, ultraviolet germicidal irradiation, and dry heat decontamination
Ludwig-Begall, L. F., Wielick, C., Jolois, O., Dams, L., Razafimahefa, R. M., Nauwynck, H., Demeuldre, P.-F., Napp, A., Laperre, J., Farnir, F., Thiry, E., Haubruge, E.
10.1101/2021.01.15.21249866 — Posted: 2021-01-15
CAR-NK Cells Effectively Target the D614 and G614 SARS-CoV-2-infected Cells
Ma, M., Badeti, S., Chen, C.-H., Pinter, A., Jiang, Q., Shi, L., Zhou, R., Xu, H., Li, Q., Gause, W., Liu, D.
10.1101/2021.01.14.426742 — Posted: 2021-01-15
Enhanced Cholesterol-dependent Hemifusion by Internal Fusion Peptide 1 of SARS Coronavirus-2 Compared to its N-terminal Counterpart
Pattnaik, G. P., Bhattacharjya, S., Chakraborty, H.
10.1101/2021.01.14.426613 — Posted: 2021-01-15
Structural characterization of cocktail-like targeting polysaccharides from Ecklonia kurome Okam and their anti-SARS-CoV-2 activities in vitro
Ding, K., Zhang, B., Chen, X., Xu, Y., Huang, C., Jin, C., Du, Z., Chen, X., Ding, Y., Sun, H., Li, M., Pei, R., Zhang, S., Su, M., Zhang, Y., Li, J.
10.1101/2021.01.14.426521 — Posted: 2021-01-15
In vivo structure and dynamics of the RNA genome of SARS-Cov-2
Zhang, Y., Huang, K., Xie, D., Lau, J. Y., Shen, W., Li, P., Wang, D., Zou, Z., Shi, S., Ren, H., Jin, M., Kudla, G., Zhao, Z.
10.1101/2021.01.15.426526 — Posted: 2021-01-15
An Estimation of Reproduction Number of SARS-CoV-2 by Age Class for Age Classes in Japan
Kurita, J., Hata, T., Sugawara, T., Ohkusa, Y., Hata, A.
10.1101/2021.01.14.21249854 — Posted: 2021-01-15
Epidemiology of post-COVID syndrome following hospitalisation with coronavirus: a retrospective cohort study
Ayoubkhani, D., Khunti, K., Nafilyan, V., Maddox, T., Humberstone, B., Diamond, I., Banerjee, A.
10.1101/2021.01.15.21249885 — Posted: 2021-01-15 Discussion: Onsite | Offsite
Persistently increased systemic ACE2 activity and Furin levels are associated with increased inflammatory response in smokers with SARS-CoV-2 COVID-19
Kaur, G., Yogeswaran, S., Muthumalage, T., Rahman, I.
10.1101/2021.01.14.21249836 — Posted: 2021-01-15
The Use of Procalcitonin as an Antimicrobial Stewardship Tool and a Predictor of Disease Severity in COVID-19
Drewett, G. P., Smibert, O. C., Holmes, N. E., Trubiano, J. A.
10.1101/2021.01.14.21249853 — Posted: 2021-01-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).